Share This Article:

White blood cell count and mortality in acute myocardial infarction

Abstract Full-Text HTML Download Download as PDF (Size:166KB) PP. 458-463
DOI: 10.4236/wjcd.2013.37072    4,152 Downloads   6,544 Views   Citations

ABSTRACT

Introduction: Coronary atherosclerosis is increasingly viewed as an inflammatory process. We assessed the relation between WBC count on admission and mortality in STEMI patients treated with primary PCI. Material & Method: Totally 205 patients with STEMI less than 24 hours before admission who admitted for primary angioplasty enrolled in study. Study end points were defined as myocardial adverse cardiac event (MACE) and mortality at one month and one year follow-up. Result: Totally 205 patients (166 men) with mean age 56 ± 11 were enrolled in study. The mean WBC count was 8983 ± 34 and mean follow-up was 12.24 months. WBC count remained a significant predictor of mortality after multivariable adjustment in one month and 12 months follow-up (p = 0.02, p = 0.04). Conclusion: Our results extend previous find-ings that WBC count is an independent marker of cardiac mortality.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Salehi, N. , Eskandarian, R. , Sanati, H. , Firouzi, A. , Shakerian, F. , Abdi, S. , Bakhshandeh, H. , Abadi, M. , Nouri, N. and Vakili-Zarch, A. (2013) White blood cell count and mortality in acute myocardial infarction. World Journal of Cardiovascular Diseases, 3, 458-463. doi: 10.4236/wjcd.2013.37072.

References

[1] Bhatt, D.L. and Topol, E.J. (2002) Need to test the arterial inflammation hypothesis. Circulation, 106, 136-140.
http://dx.doi.org/10.1161/01.CIR.0000021112.29409.A2
[2] Alexander, R.W. (1994) Inflammation and coronary artery disease. New England Journal of Medicine, 331, 468-469.
http://dx.doi.org/10.1056/NEJM199408183310709
[3] Gurm, H.S., Bhatt, D.L., Lincoff, A.M., Tcheng, J.E., Kereiakes, D.J., Kleiman, N.S., Jia, G. and Topol, E.J. (2003) Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: Insights from the EPIC, EPILOG, and EPISTENT trials. Heart, 89, 1200-1204.
http://dx.doi.org/10.1136/heart.89.10.1200
[4] Ross, R. (1999) Atherosclerosis—An inflammatory disease. New England Journal of Medicine, 340, 115-126.
http://dx.doi.org/10.1056/NEJM199901143400207
[5] Libby, P., Ridker, P.M. and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 1135-1143.
http://dx.doi.org/10.1161/hc0902.104353
[6] Friedman, G.D., Klatsky, A.L. and Siegelaub, A.B. (1974) The leukocyte count as a predictor of myocardial infarction. New England Journal of Medicine, 290, 1275-1278.
http://dx.doi.org/10.1056/NEJM197406062902302
[7] Manttari, M., Manninen, V., Koskinen, P., Huttunen, J.K., Oksanen, E., Tenkanen, L., Heinonen, O.P. and Frick, M.H. (1992) Leukocytes as a coronary risk factor in a dyslipidemic male population. American Heart Journal, 123, 873-877.
http://dx.doi.org/10.1016/0002-8703(92)90690-W
[8] Schlant, R.C., Forman, S., Stamler, J. and Canner, P.L. (1982) The natural history of coronary heart disease: Prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project. Circulation, 66, 401-414.
http://dx.doi.org/10.1161/01.CIR.66.2.401
[9] Lowe, G.D., Machado, S.G., Krol, W.F., Barton, B.A. and Forbes, CD. (1985) White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost, 54, 700-703.
[10] Sabatine, M.S., Morrow, D.A., Cannon, C.P., Murphy, S.A., Demopoulos, L.A., DiBattiste, P.M., McCabe, C.H., Braunwald, E. and Gibson, C.M. (2002) Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: A TACTICS-TIMI 18 (treat angina with aggrastat and determine cost of therapy with an invasive or conservative strategy-thrombolysis in myocardial infarction 18 trial) substudy. Journal of the American College of Cardiology, 40, 1761-1768.
http://dx.doi.org/10.1016/S0735-1097(02)02484-1
[11] Mueller, C., Neumann, F.J., Perruchoud, A.P. and Buettner, H.J. (2003) White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart, 89, 389-392. http://dx.doi.org/10.1136/heart.89.4.389
[12] Cannon, C.P., McCabe, C.H., Wilcox, R.G., Bentley, J.H. and Braunwald, E. (2001) Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. American Journal of Cardiology, 87, 636-639. http://dx.doi.org/10.1016/S0002-9149(00)01444-2
[13] Hajj-Ali, R., Zareba, W., Ezzeddine, R. and Moss, A.J. (2001) Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. American Journal of Cardiology, 88, 1221-1224.
http://dx.doi.org/10.1016/S0002-9149(01)02080-X
[14] Furman, M.I., Becker, R.C., Yarzebski, J., Savegeau, J., Gore, J.M. and Goldberg, R.J. (1996) Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. American Journal of Cardiology, 78, 945-948.
http://dx.doi.org/10.1016/S0002-9149(96)00473-0
[15] Barron, H.V., Harr, S.D., Radford, M.J., Wang, Y. and Krumholz, H.M. (2001) The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age: Findings from the cooperative cardiovascular project. Journal of the American College of Cardiology, 38, 1654-1661.
http://dx.doi.org/10.1016/S0735-1097(01)01613-8
[16] Cannon, C.P., McCabe, C.H., Wilcox, R.G., et al. (2001) Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 investigators. American Journal of Cardiology, 87, 636-639.
http://dx.doi.org/10.1016/S0002-9149(00)01444-2
[17] Furman, M.I., Becker, R.C., Yarzebski, J., Savegeau, J., Gore, J.M. and Goldberg, R.J. (1996) Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. American Journal of Cardiology, 78, 945-948.
http://dx.doi.org/10.1016/S0002-9149(96)00473-0
[18] Kruk, M., Karcz, M., Przyluski, J., Bekta, P., Kepka, C., Kalińczuk, L., Pregowski, J., Kaczmarska, E., Demkow, M., Chmielak, Z., Witkowski, A. and Ruzyllo, W. (2007) White blood cell count adds prognostic information to the thrombolysis in myocardial infarction in risk index in patients following primary percutaneous intervention (ANIN myocardial infarction registry). International Journal of Cardiology, 116, 376-382.
http://dx.doi.org/10.1016/j.ijcard.2006.03.061
[19] Pellizzon, G.G., Dixon, S.R., Stone, G.W., Cox, D.A., Mattos, L., Boura, J.A., Grines, L.L., Addala, S., O’Neill, W.W. and Grines, C.L. (2003) Stent PAMI Investigators. Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). American Journal of Cardiology, 91, 729-731.
http://dx.doi.org/10.1016/S0002-9149(02)03416-1
[20] Gurm, H., Gupta, R., Lauer, M., et al. (2001) The baseline leucocyte count is a strong and independent predictor of mortality in patients undergoing percutaneous coronary artery interventions: Implications of arterial inflamemation. Circulation, 104, II775.
[21] Danesh, J., Collins, R., Appleby, P., et al. (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA, 279, 1477-1482.
http://dx.doi.org/10.1001/jama.279.18.1477
[22] Danesh, J., Whincup, P., Walker, M., et al. (2000) Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ, 321, 199-204. http://dx.doi.org/10.1136/bmj.321.7255.199
[23] Yarnell, J.W., Baker, I.A., Sweetnam, P.M., et al. (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation, 83, 836-844.
http://dx.doi.org/10.1161/01.CIR.83.3.836
[24] de Labry, L.O., Campion, E.W., Glynn, R.J., et al. (1990) White blood cell count as a predictor of mortality: Results over 18 years from the normative aging study. Journal of Clinical Epidemiology, 43, 153-157.
http://dx.doi.org/10.1016/0895-4356(90)90178-R
[25] Barron, H.V., Cannon, C.P., Murphy, S.A., et al. (2000) Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: A thrombolysis in myocardial infarction 10 substudy. Circulation, 102, 2329-2334.
http://dx.doi.org/10.1161/01.CIR.102.19.2329
[26] Cannon, C.P., McCabe, C.H., Wilcox, R.G., Bentley, J.H. and Braunwald, E. (2001) Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina. American Journal of Cardiology, 87, 636-639.
http://dx.doi.org/10.1016/S0002-9149(00)01444-2
[27] Furmann, M.I., Becker, R.C., Yarzebski, J., Savegeau, J., Gore, J.M. and Golgberg, R.J. (1996) Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. American Journal of Cardiology, 78, 945-948.
http://dx.doi.org/10.1016/S0002-9149(96)00473-0
[28] Mehran, R., Dangas, G., Parise, H., Guagliumi, G., Witzenbichler, B. and Grinfeld, L. (2008) Prognostic impact of the baseline white blood cell count in patients with acute myocardial infarction undergoing primary PCI: Results from the HORIZONS-AMI trial. Circulation, 118, S973.
[29] Jurewitz, D., Pessegueiro, A., Zimmer, R., Bhatia, R., Tobis, J. and Lee, M. (2009) Preprocedural white blood cell count as a predictor of death and major adverse cardiac events in patients undergoing percutaneous coronary intervention with drug-eluting stents. Journal of Invasive Cardiology, 21, 202-206.
[30] Ndrepepag, G., Brauns, S., Iijimar, R., Keta, D., Byrner, A., Schulz, S., Mehilli, J., Schomig, A. and Kastrati, A. (2009) Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention. Clinical Science, 116, 651-658.
[31] Ferrieres, J., et al. (2004) Endothelial cell markers and risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study. Circulation, 109, 1343-1348.
http://dx.doi.org/10.1161/01.CIR.0000120705.55512.EC
[32] Avramkis, G., Papadimitraki, E., Papakonstandinou, D., Liakou, K., Zidianakis, M., Dermitzakis, A., et al. (2007) Platelets and white cell subpopulations among patients with myocardial infarction and unstable angina. Platelets, 18, 16-23. http://dx.doi.org/10.1080/09537100600800412
[33] Gibson, C.M., Cannon, C.P., Murphy, S.A., Ryan, K.A., Mesley, R., Marble, S.J., McCabe, C.H., Van De Werf, F. and Braunwald, E. (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation, 101, 125-130.
http://dx.doi.org/10.1161/01.CIR.101.2.125
[34] Kloner, R.A., Ganote, C.E. and Jennings, R.B. (1974) The “no-reflow” phenomenon after temporary coronary occlusion in the dog. Journal of Clinical Investigation, 54, 1496-1508.
http://dx.doi.org/10.1172/JCI107898

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.